Connection
Christina Aquilante to Tacrolimus
This is a "connection" page, showing publications Christina Aquilante has written about Tacrolimus.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.459 |
|
|
|
-
Deininger KM, Anderson HD, Patrinos GP, Mitropoulou C, Aquilante CL. Cost-effectiveness analysis of CYP3A5 genotype-guided tacrolimus dosing in solid organ transplantation using real-world data. Pharmacogenomics J. 2024 May 15; 24(3):14.
Score: 0.799
-
Deininger KM, Vu A, Page RL, Ambardekar AV, Lindenfeld J, Aquilante CL. CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients. Clin Transplant. 2016 09; 30(9):1074-81.
Score: 0.464
-
Liu M, Hernandez S, Aquilante CL, Deininger KM, Lindenfeld J, Schlendorf KH, Van Driest SL. Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients. Pharmacogenomics J. 2024 Feb 15; 24(2):4.
Score: 0.196